Hepcidin inhibition on the effect of osteogenesis in zebrafish

Biochemical and Biophysical Research Communications

Volumn 476, Issue 1, 2016, Pages 1-6

  Jiang, Yu ^a,b,d   Yan, Yilin ^c   Wang, Xiao ^a,d   Zhu, Guoxing ^b   Xu, You Jia ^a,d  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b WUXI NO 2 PEOPLE S HOSPITAL   (China)

^c UNIVERSITY OF OREGON   (United States)

^d SOOCHOW UNIVERSITY   (China)

Author keywords

Hepcidin; Iron overload; Morpholino; Zebrafish

Indexed keywords

HEPCIDIN; MESSENGER RNA; MORPHOLINO OLIGONUCLEOTIDE; HEPCIDIN PROTEIN, ZEBRAFISH; IRON; ZEBRAFISH PROTEIN;

ALP GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; GENE; IN SITU HYBRIDIZATION; IN VITRO STUDY; IN VIVO STUDY; IRON OVERLOAD; MICROINJECTION; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RUNX2A GENE; RUNX2B GENE; SP7 GENE; ZEBRA FISH; AMINO ACID SEQUENCE; ANIMAL; BONE; CHEMISTRY; COMPLICATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYLOGENY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; BONE AND BONES; DOWN-REGULATION; GENE KNOCKDOWN TECHNIQUES; HEPCIDINS; IRON; IRON OVERLOAD; MORPHOLINOS; OSTEOBLASTS; OSTEOGENESIS; PHYLOGENY; RNA, MESSENGER; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84969940491     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.05.118     Document Type: Article

References (32)

1. M.W. Hentze, M.U. Muckenthaler, and N.C. Andrews Balancing acts: molecular control of mammalian iron metabolism Cell 117 2004 285 297
2. E. Nemeth, M.S. Tuttle, J. Powelson, M.B. Vaughn, A. Donovan, D.M. Ward, T. Ganz, and J. Kaplan Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization Science 306 2004 2090 2093
3. I. De Domenico, D. McVey Ward, and J. Kaplan Regulation of iron acquisition and storage: consequences for iron-linked disorders Nat. Rev. Mol. Cell Biol. 9 2008 72 81
4. J. Jian, E. Pelle, and X. Huang Iron and menopause: does increased iron affect the health of postmenopausal women? Antioxid. Redox Signal 11 2009 2939 2943
5. X. Huang, Y. Xu, and N.C. Partridge Dancing with sex hormones, could iron contribute to the gender difference in osteoporosis? Bone 55 2013 458 460
6. G.F. Li, Y.Z. Pan, P. Sirois, K. Li, and Y.J. Xu Iron homeostasis in osteoporosis and its clinical implications Osteoporos. Int. 23 2012 2403 2408
7. P. Guggenbuhl, P. Brissot, and O. Loreal Miscellaneous non-inflammatory musculoskeletal conditions. Haemochromatosis: the bone and the joint Best. Pract. Res. Clin. Rheumatol. 25 2011 649 664
8. A. Yadav, and E.J. Carey Osteoporosis in chronic liver disease Nutr. Clin. Pract. 28 2013 52 64
9. B.J. Kim, S.H. Ahn, S.J. Bae, E.H. Kim, S.H. Lee, H.K. Kim, J.W. Choe, J.M. Koh, and G.S. Kim Iron overload accelerates bone loss in healthy postmenopausal women and middle-aged men: a 3-year retrospective longitudinal study J. Bone Min. Res. 27 2012 2279 2290
10. J. Tsay, Z. Yang, F.P. Ross, S. Cunningham-Rundles, H. Lin, R. Coleman, P. Mayer-Kuckuk, S.B. Doty, R.W. Grady, P.J. Giardina, A.L. Boskey, and M.G. Vogiatzi Bone loss caused by iron overload in a murine model: importance of oxidative stress Blood 116 2010 2582 2589
11. G. Liu, P. Men, G.H. Kenner, and S.C. Miller Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats Hemoglobin 32 2008 181 190
12. M. Doyard, N. Fatih, A. Monnier, M.L. Island, M. Aubry, P. Leroyer, R. Bouvet, G. Chales, J. Mosser, O. Loreal, and P. Guggenbuhl Iron excess limits HHIPL-2 gene expression and decreases osteoblastic activity in human MG-63 cells Osteoporos. Int. 23 2012 2435 2445
13. N. Li, K. Felber, P. Elks, P. Croucher, and H.H. Roehl Tracking gene expression during zebrafish osteoblast differentiation Dev. Dyn. 238 2009 459 466
14. C. Xu, M. Tabebordbar, S. Iovino, C. Ciarlo, J. Liu, A. Castiglioni, E. Price, M. Liu, E.R. Barton, C.R. Kahn, A.J. Wagers, and L.I. Zon A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species Cell 155 2013 909 921
15. A. Fleming, M. Sato, and P. Goldsmith High-throughput in vivo screening for bone anabolic compounds with zebrafish J. Biomol. Screen 10 2005 823 831
16. P.B. Yu, C.C. Hong, C. Sachidanandan, J.L. Babitt, D.Y. Deng, S.A. Hoyng, H.Y. Lin, K.D. Bloch, and R.T. Peterson Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism Nat. Chem. Biol. 4 2008 33 41
17. S. Zhang, M. Xu, J. Huang, L. Tang, Y. Zhang, J. Wu, S. Lin, and H. Wang Heme acts through the Bach1b/Nrf2a-MafK pathway to regulate exocrine peptidase precursor genes in porphyric zebrafish Dis. Model Mech. 7 2014 837 845
18. C.B. Kimmel, A. DeLaurier, B. Ullmann, J. Dowd, and M. McFadden Modes of developmental outgrowth and shaping of a craniofacial bone in zebrafish PLoS One 5 2010 e9475
19. P.G. Fraenkel, D. Traver, A. Donovan, D. Zahrieh, and L.I. Zon Ferroportin1 is required for normal iron cycling in zebrafish J. Clin. Investig. 115 2005 1532 1541
20. G.Y. Zhao, L.P. Zhao, Y.F. He, G.F. Li, C. Gao, K. Li, and Y.J. Xu A comparison of the biological activities of human osteoblast hFOB1.19 between iron excess and iron deficiency Biol. Trace Elem. Res. 150 2012 487 495
21. A. Zarjou, V. Jeney, P. Arosio, M. Poli, E. Zavaczki, G. Balla, and J. Balla Ferritin ferroxidase activity: a potent inhibitor of osteogenesis J. Bone Min. Res. 25 2010 164 172
22. Y.F. He, Y. Ma, C. Gao, G.Y. Zhao, L.L. Zhang, G.F. Li, Y.Z. Pan, K. Li, and Y.J. Xu Iron overload inhibits osteoblast biological activity through oxidative stress Biol. Trace Elem. Res. 152 2013 292 296
23. J. Arezes, and E. Nemeth Hepcidin and iron disorders: new biology and clinical approaches Int. J. Lab Hematol. 37 Suppl 1 2015 92 98
24. G.F. Li, Y.J. Xu, Y.F. He, B.C. Du, P. Zhang, D.Y. Zhao, C. Yu, C.H. Qin, and K. Li Effect of hepcidin on intracellular calcium in human osteoblasts Mol. Cell Biochem. 366 2012 169 174
25. A. Habib, R. Polavarapu, V. Karmali, L. Guo, R. Van Dam, Q. Cheng, H. Akahori, O. Saeed, M. Nakano, K. Pachura, C.C. Hong, E. Shin, F. Kolodgie, R. Virmani, and A.V. Finn Hepcidin-ferroportin axis controls toll-like receptor 4 dependent macrophage inflammatory responses in human atherosclerotic plaques Atherosclerosis 241 2015 692 700
26. S. Schulte-Merker, and D.Y. Stainier Out with the old, in with the new: reassessing morpholino knockdowns in light of genome editing technology Development 141 2014 3103 3104
27. G.A. Wallis, B. Rash, W.A. Sweetman, J.T. Thomas, M. Super, G. Evans, M.E. Grant, and R.P. Boot-Handford Amino acid substitutions of conserved residues in the carboxyl-terminal domain of the alpha 1(X) chain of type X collagen occur in two unrelated families with metaphyseal chondrodysplasia type Schmid Am. J. Hum. Genet. 54 1994 169 178
28. O. Makitie, M. Susic, L. Ward, C. Barclay, F.H. Glorieux, and W.G. Cole Schmid type of metaphyseal chondrodysplasia and COL10A1 mutations-findings in 10 patients Am. J. Med. Genet. A 137A 2005 241 248
29. O. Jacenko, P.A. LuValle, and B.R. Olsen Spondylometaphyseal dysplasia in mice carrying a dominant negative mutation in a matrix protein specific for cartilage-to-bone transition Nature 365 1993 56 61
30. K.M. Kwan, M.K. Pang, S. Zhou, S.K. Cowan, R.Y. Kong, T. Pfordte, B.R. Olsen, D.O. Sillence, P.P. Tam, and K.S. Cheah Abnormal compartmentalization of cartilage matrix components in mice lacking collagen X: implications for function J. Cell Biol. 136 1997 459 471
31. T. Komori, H. Yagi, S. Nomura, A. Yamaguchi, K. Sasaki, K. Deguchi, Y. Shimizu, R.T. Bronson, Y.H. Gao, M. Inada, M. Sato, R. Okamoto, Y. Kitamura, S. Yoshiki, and T. Kishimoto Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts Cell 89 1997 755 764
32. K. Tamura, G. Stecher, D. Peterson, A. Filipski, and S. Kumar MEGA6: molecular evolutionary genetics analysis version 6.0 Mol. Biol. E 30 2013 2725 2729